A study [86] explored the role of BCL-2 as a potential therapeutic target in breast cancer and showed a sensitization of BCL-2 expressing breast cancers to chemotherapy by the BH3 mimetic ABT-737. This evidence concerns the gene BCL2 and breast carcinoma.